文献速递慢性肾脏病血液净化与透析

慢性肾脏病、肥胖、心血管代谢危险因素与重症COVID-19结局的关联

Association Between CKD, Obesity, Cardiometabolic Risk Factors, and Severe COVID-19 Outcomes.
PubMed 文献 · Kidney Int Rep · 2023-01-14

这项全国性病例对照研究纳入4684例因重症COVID-19入住ICU需机械通气的患者和46840例按年龄、性别和居住区匹配的对照,分析慢性肾脏病(CKD)与重症COVID-19的关联。结果显示CKD与重症COVID-19(OR 2.20)、ICU内连续性肾脏替代治疗(OR 7.36)及ICU入院后死亡(OR 2.51)相关,且该风险在不合并糖尿病者中更高。

要点

  • CKD与重症COVID-19风险升高相关(OR 2.20,95%CI 1.85-2.62)。
  • CKD与ICU内CRRT(OR 7.36)及ICU入院后死亡(OR 2.51)相关。
  • CKD相关重症风险在无糖尿病者(OR 2.76)高于糖尿病者(OR 1.88)。

核心结论

  • CKD尤其是终末期CKD是重症COVID-19及ICU入院后死亡的重要危险因素,在体重正常且无2型糖尿病的患者中同样如此。

研究设计与样本

  • 全国性病例对照研究,数据来自法定国家登记库,纳入4684例因重症COVID-19入住ICU需机械通气的患者(病例)和46840例按年龄、性别和居住区匹配的基于人群的对照。
  • 采用逻辑回归计算重症COVID-19与暴露因素关联的比值比(OR)及95%置信区间(CI),校正混杂因素,并按体重指数(BMI)进行亚组分析及按2型糖尿病匹配。

主要发现

  • 中位年龄64岁,女性占27.7%。
  • 病例中CKD占5.4%、对照中占1.5%;终末期CKD分别占1.9%和0.3%。
  • CKD与重症COVID-19相关(OR 2.20,95%CI 1.85-2.62),与ICU内连续性肾脏替代治疗(CRRT)相关(OR 7.36,95%CI 5.39-10.05),与ICU入院后任何时间死亡相关(OR 2.51,95%CI 1.96-3.22)。
  • CKD与重症COVID-19的风险关联在不同体重间无显著差异,但在无糖尿病者中(OR 2.76,95%CI 2.15-3.55)高于糖尿病者(OR 1.88,95%CI 1.37-2.59)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic kidney disease (CKD) is a risk factor for acquiring severe COVID-19, but underlying mechanisms are unknown. We aimed to study the risk associated with CKD for severe COVID-19 outcomes in relation to body mass index (BMI) and diabetes because they are common risk factors for both CKD and severe COVID-19. METHODS: This nationwide case-control study with data from mandatory national registries included 4684 patients (cases) admitted to the intensive care units (ICUs) requiring mechanical ventilation and 46,840 population-based controls matched by age, sex, and district of residency. Logistic regression was used to calculate odds ratios (ORs) with 95% confidence intervals (CIs) for associations between severe COVID-19 and exposures with adjustment for confounders, in subgroups by BMI, and matched by type 2 diabetes. RESULTS: The median age was 64 years, and 27.7% were female. CKD was observed in 5.4% of the cases and 1.5% of the controls, whereas 1.9% and 0.3% had end-stage CKD, respectively. CKD was associated with severe COVID-19 (OR, 2.20 [95% CI, 1.85-2.62]), continuous renal replacement therapy (CRRT) in ICU (OR, 7.36 [95% CI, 5.39-10.05]), and death any time after ICU admission (OR, 2.51 [95% CI, 1.96-3.22]). The risk associated with CKD for severe COVID-19 did not differ significantly by weight but was higher in those without diabetes (OR, 2.76 [95% CI, 2.15-3.55]) than in those with diabetes (OR, 1.88 [95% CI, 1.37-2.59]). CONCLUSION: CKD, especially end-stage CKD, is an important risk factor for severe COVID-19 and death after ICU admission also in patients with normal BMI and without type 2 diabetes.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Sörling A, Nordberg P, Hofmann R, et al. Association Between CKD, Obesity, Cardiometabolic Risk Factors, and Severe COVID-19 Outcomes. Kidney Int Rep. 2023. PMID: 36685734. doi:10.1016/j.ekir.2023.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。